Psychotic Disorders
The ICHOM Standard Set for Psychotic Disorders is the result of hard work by a group of leading psychiatrists, psychologists, mental health experts, measurement experts, and lived experience experts. It represents the outcomes that matter most to adults and adolescents with psychosis. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their service users.
- Defined by Number of Hospitalisations in the Past 12 Months
- Defined by CHIME Domains: Connectedness, Hope and Optimism, Identity, Meaning and Purpose, Empowerment
- Defined by Health-Related Quality of Life
- Tracked via the Patient Health Questionnaire 9-Item
- Tracked via the Modified Colorado Symptom Index
- Tracked via the Recovering Quality of Life – 20-Item Version
- Tracked via the Altman Self-Rating Mania Scale in Populations with Bipolar Type I Disorder
- Tracked via the PROMIS Short Form v1.0 – Sleep Disturbance 4a
- Tracked via the Number of Hospitalisations
- Tracked via the WHO Disability Assessment Schedule 2.0 – 12-Item Version
- Tracked via the KIDSCREEN-10 Index in Adolescent Specialist Services
- Tracked via the Patient Health Questionnaire 15-Item
- Tracked via the Glasgow Antipsychotic Side-Effect Scale
Psychotic Disorders community group
The ICHOM Working Group on Psychotic Disorders is currently underway.
Team that developed this standard
PROJECT TEAM
Chair | Donald Addington | University of Calgary
Research Fellow | Emily McKenzie | University of Calgary
Project Managers | Lucy Matkin / Luz Sousa Fialho | ICHOM
Research Associates | Beth Jagger / Christiana Ilesanmi / Ifeoma Nneka Emelurumonye / Shannon Quinney / Timea Gintner | ICHOM
AUSTRALIA
Grant Sara | NSW Ministry of Health / University of Sydney
Tim Coombs | Illawarra Institute for Mental Health University of Wollongong
CANADA
Elizabeth Anderson*
DENMARK
Lone Baandrup | Mental Health Centre Copenhagen
GREECE
Fokion Dimitriadis*
INDIA
Amrit Bakhshy | Schizophrenia Awareness Association, Pune*
ISRAEL
David Roe | University of Haifa
MEXICO
Dania Nimbe Lima Sanchez | Medicine School, Universidad Nacional Autónoma de México
NETHERLANDS
Niels C. L. Mulder | Erasmus MC, Rotterdam
UNITED KINGDOM
Alison Brabban | Tees, Esk & Wear Valleys NHS Foundation Trust / NHS England
Anju D. Keetharuth | School of Health and Related Research, University of Sheffield
Caroline Cupitt | South London and Maudsley NHS Foundation Trust
Farhad Shokraneh | University of Nottingham
Jacqueline Sin | University of Reading
Paul McCrone | Institute for Lifecourse Development, Faculty of Education, Health and Human Sciences, University of Greenwich
UNITED STATES
Christoph U. Correll | Hofstra Northwell School of Medicine / Feinstein Institute for Medical Research / The Zucker Hillside Hospital, Department of Psychiatry
Kristen Woodberry | Maine Medical Center Research Institute
Mary D. Moller | Pacific Lutheran University, Tacoma, WA
*Patient representative
